DB12797InvestigationalProtein Based Therapies
Ecromeximab has been used in trials studying the treatment of Cutaneous Melanoma and Metastatic Melanoma.
- Also known as
- KW2871
Resolves to
Compound
What you can answer from here — as of February 21, 2021
Which companies are running trials of Ecromeximab, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account